Texas State Board of Pharmacy Awards Contract to PTCB
The Texas State Board of Pharmacy (TSBP) has awarded a contract designating PTCB as the only TSBP-recognized certifying body for pharmacy technicians in the state. The contract requires
pharmacy technicians in Texas to first meet PTCB’s initial certification requirements, including passing the Pharmacy Technician Certification Exam (PTCE), before applying for state registration. The agreement will take effect in September and replace a previous contract with PTCB due to expire.
PTCB Adds New Patient Safety CE Requirement for Recertification
Effective in April, CPhTs eligible torecertify are required to complete one hour of CE in patient safety. PTCB has adopted the Accreditation Council for Pharmacy Education (ACPE) definition of patient safety CE (topic 05) described in the ACPE Policy and Procedures Manual. While PTCB-acceptable patient safety CE must be based on ACPE's topic 05 definition, PTCB will not require the hours to be earned only from
ACPE-accredited providers. All CPhTs applying to renew certification must
fulfill this requirement. Read the full story. Visit PTCB's website for examples of CEs.
Coming Up
- June 29-July 2: PTCB will exhibit at the American School Counselor Association Annual Meeting in Orlando, FL.
- July 10-12: PTCB will exhibit and present at the Pharmacy Technician Educators Council Annual Conference in Lexington, KY.
- July 17: PTCB will present and exhibit at the Minnesota Society of Health-System Pharmacists Pharmacy Technician Conference in Brooklyn Center, MN.
July 24-26: PTCB will attend the American Association of Pharmacy
Technicians Annual Conference in Pittsburgh, PA.
New Online Community for Pharmacy Technicians
The American Society of Health-System Pharmacists (ASHP) has launched a new online resource for pharmacy technicians.
Reminder: Don't Dispense Products With More Than 325 Mg Acetaminophen
FDA is reminding health care professionals to stop prescribing, and pharmacists to stop dispensing, prescription combination drug products that contain more than 325 milligrams (mg) of acetaminophen per tablet, capsule, or other dosage unit. If a pharmacist receives a prescription for a combination product with more than 325 mg per dosage unit, FDA recommends they contact the prescriber to discuss a product with a lower dose of acetaminophen. These products were voluntarily withdrawn by the manufacturers at FDA’s request to protect consumers from the risk of severe liver damage, which can result from taking too much acetaminophen. Read the full story.